Inhibiting NSD1 enzyme and/or NSD1 downstream Akt/mTORC1 signaling, and to target/disrupt autophagy could be an exciting novel therapeutic strategy in HPV-negative HNSCC. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.